促进我国第三方药品物流发展的监管对策研究  

Research on the Administrative Measures for Developing Third-party Drug Logistics in China

作　　者：洪钢 

机构地区：[1]江苏省食品药品监督管理局,南京210008

出　　处：《中国药事》2014年第11期1191-1195,共5页Chinese Pharmaceutical Affairs

摘　　要：目的为促进我国第三方药品物流快速发展,探讨监管对策。方法简要介绍我国第三方药品物流的定义、运作模式、竞争优势和发展现状,并分别从医药企业客户、第三方药品物流企业、政府和行业监管等三个物流相关方,对当前第三方药品物流存在的主要问题及其原因进行分析。结果与结论完善监管体制、破除地方保护、健全政策法规、加快标准化和信息化建设、培育权威行业协会、加强专业人才培养,将会进一步促进我国第三方药品物流的发展壮大,提高药品流通市场规范化、规模化、集约化程度。Objective To provide administrative measures for developing third-party drug logistics in China.Methods Based on the definition,operation mode,competitive advantage and the current situation of third-party drug logistics in China,the main problems and the corresponding causes were analyzed from the aspects of the customer,provider and administrator.Results and Conclusion The development and growth of the third-party drug logistics can be further promoted by aperfect mechanism,a fair market,sound policies,advanced information technology,unified standard,authoritative industry associations and strengthened professional training.As a result,the drug distribution market will be improved in terms of standard,scale and intensity.

关 键 词：药品流通 第三方物流 物流管理 发展对策 

分 类 号：R95[医药卫生—药学]